Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

Karson S Putt (Inventor), Jennifer M Pearson (Inventor), Grace Chen (Inventor), Paul J Hergenrother (Inventor), Quinn P Peterson (Inventor), Diana C West (Inventor)

Research output: Patent

Abstract

Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.
Original languageEnglish (US)
U.S. patent number9102661
Filing date7/1/14
StatePublished - Aug 11 2015

Fingerprint

Dive into the research topics of 'Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs'. Together they form a unique fingerprint.

Cite this